Quarterly Result12 Feb 2026, 07:42 pm
Welcure Drugs & Pharmaceuticals Ltd Announces Unaudited Financials for Q3 2025
AI Summary
Welcure Drugs & Pharmaceuticals Ltd has announced its unaudited financial results for the 3rd quarter ended on 31st December, 2025. The Board of Directors approved the financial results in a meeting held on 12th February, 2026. The company's financial results were reviewed by Sarang Shivajirao Chavan & Associates, the independent auditor.
Key Highlights
- Welcure Drugs & Pharmaceuticals Ltd announced its unaudited financial results for Q3 2025.
- The Board of Directors approved the financial results in a meeting held on 12th February, 2026.
- The financial results were reviewed by Sarang Shivajirao Chavan & Associates.
- The company is advised to take external confirmations via email from debtors, creditors, and parties related to investments, deposits, and loans.
- The independent auditor, Sarang Shivajirao Chavan & Associates, did not express an opinion on the statement due to insufficient and inappropriate audit evidence.
Price Impact
More from WELCURE